How to buy Organovo stock

Organovo Holdings, Inc is a diagnostics & research business based in the US. Organovo shares (ONVO) are listed on the NASDAQ and all prices are listed in US Dollars. Organovo employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

Organovo share price

Use our graph to track the performance of ONVO stocks over time.

Organovo shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$6.02 - $23.92
50-day moving average	$9.89
200-day moving average	$11.04
Wall St. target price	$3.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.21

Buy Organovo shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Organovo stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Organovo Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Organovo financials

Gross profit TTM	$-3,416,000
Return on assets TTM	-26.93%
Return on equity TTM	-68.21%
Profit margin	0%
Book value	$2.92
Market capitalisation	$68.4 million

TTM: trailing 12 months

Shorting Organovo shares

There are currently 444,132 Organovo shares held short by investors – that's known as Organovo's "short interest". This figure is 3.8% down from 461,618 last month.

There are a few different ways that this level of interest in shorting Organovo shares can be evaluated.

Organovo's "short interest ratio" (SIR)

Organovo's "short interest ratio" (SIR) is the quantity of Organovo shares currently shorted divided by the average quantity of Organovo shares traded daily (recently around 233753.68421053). Organovo's SIR currently stands at 1.9. In other words for every 100,000 Organovo shares traded daily on the market, roughly 1900 shares are currently held short.

However Organovo's short interest can also be evaluated against the total number of Organovo shares, or, against the total number of tradable Organovo shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Organovo's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Organovo shares in existence, roughly 60 shares are currently held short) or 0.0784% of the tradable shares (for every 100,000 tradable Organovo shares, roughly 78 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Organovo.

Find out more about how you can short Organovo stock.

Organovo share dividends

We're not expecting Organovo to pay a dividend over the next 12 months.

Have Organovo's shares ever split?

Organovo's shares were split on a 1:20 basis on 18 August 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Organovo shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Organovo shares which in turn could have impacted Organovo's share price.

Organovo share price volatility

Over the last 12 months, Organovo's shares have ranged in value from as little as $6.018 up to $23.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Organovo's is 0.7226. This would suggest that Organovo's shares are less volatile than average (for this exchange).

Organovo overview

Organovo Holdings, Inc. , a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases; and NovoTissues liver product using cells from a liver donor and cells from an umbilical cord donor. The company was founded in 2007 and is headquartered in Solana Beach, California. .

Frequently asked questions

• What percentage of Organovo is owned by insiders or institutions?

  Currently 1.857% of Organovo shares are held by insiders and 29.102% by institutions.

• How many people work for Organovo?

  Latest data suggests 7 work at Organovo.

• When does the fiscal year end for Organovo?

  Organovo's fiscal year ends in March.

• Where is Organovo based?

  Organovo's address is: 440 Stevens Avenue, Solana Beach, CA, United States, 92075

• What is Organovo's ISIN number?

  Organovo's international securities identification number is: US68620A2033

• What is Organovo's CUSIP number?

  Organovo's Committee on Uniform Securities Identification Procedures number is: 62620A104